The downgrade from Overweight to Equal-Weight suggests that Barclays sees less potential for outperformance in Procter & Gamble's stock. Maintaining the price target at $163 indicates that the analyst does not expect significant price movement in the short term. This downgrade could lead to a negative sentiment among investors, potentially putting downward pressure on the stock price.